ReviewJournal of thoracic disease2017

The role of peptide receptor radionuclide therapy in advanced/metastatic thoracic neuroendocrine tumors.

Lisa Bodei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.